Local Institution
Tsukuba, Ibaraki 3058576
0 studies enrolling now · 3 studies all time
What they study most
Acute Coronary Syndrome, Sjogrens Disease, Squamous Cell Carcinoma of the Head and Neck
Studies at this site
- Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer — Completed
- A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome — Completed
- Phase III Acute Coronary Syndrome — Stopped early